OAM
IGMS

Oxford Asset Management’s IGM Biosciences IGMS Stock Holding History

Oxford Asset Management’s Portfolio IGMS Stock Details IGMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-51,458
Closed -$1.96M – 728
2019
Q4 		$1.96M Sell
51,458
-53,094
-51% -$1.33M 0.05% 429
2019
Q3 		$1.86M Buy
+104,552
New +$2.11M 0.04% 593

Other funds holding IGMS

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Oxford Asset Management's IGMS Position: Q1 2020 in Review

Oxford Asset Management sold out of IGM Biosciences (IGMS) in Q1 2020, closing a stake of 51,458 shares — an estimated $1.96M sold.

Oxford Asset Management first reported a position in IGMS in Q3 2019 and held it in 2 quarters. The position peaked at $1.96M in Q4 2019. 62 funds tracked by Wall St. Rank hold IGMS as of Q1 2020.

  • Oxford Asset Management reported no remaining IGM Biosciences position as of Q1 2020 after selling out during the quarter.
  • Oxford Asset Management sold 51,458 IGM Biosciences shares in Q1 2020, an estimated $1.96M.
  • Oxford Asset Management first reported a position in IGM Biosciences in Q3 2019 and held it in 2 quarters.
  • Oxford Asset Management's IGM Biosciences position peaked at $1.96M in Q4 2019.
  • 62 funds tracked by Wall St. Rank held IGM Biosciences as of Q1 2020.

Based on Oxford Asset Management's 13F filing for Q1 2020, filed 15 May 2020.